Document
Exhibit 99.1
|
|
|
|
|
|
|
Kulicke & Soffa Pte. Ltd.
23A Serangoon North Ave 5
Singapore 554369
+65 6880-9600 main
Co. Regn. No. 199902120H
|
|
Kulicke and Soffa Industries, Inc.
1005 Virginia Drive
Fort Washington, PA 19034 USA
+1-215-784-6000 main
www.kns.com
|
Kulicke & Soffa Reports Second Quarter 2025 Results
Singapore – May 6, 2025 – Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) (“Kulicke & Soffa,” “K&S,” “our,” or the “Company”), today announced financial results of its second fiscal quarter ended March 29, 2025. The Company reported second quarter net revenue of $162.0 million, net loss of $84.5 million, representing EPS of $(1.59) per fully diluted share, and non-GAAP net loss of $27.9 million, representing non-GAAP EPS of $(0.52) per fully diluted share.
On March 31, 2025, the Company disclosed that its Board of Directors had approved a plan related to the intended cessation of its Electronics Assembly ("EA") equipment business. During the second fiscal quarter 2025, pre-tax charges related to this intended cessation, including impairments, were approximately $86.6 million and represented the majority of anticipated expenses.
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly Results - U.S. GAAP |
| |
Fiscal Q2 2025 |
Change vs.
Fiscal Q2 2024 |
Change vs.
Fiscal Q1 2025 |
| Net Revenue |
$162.0 million |
down 5.9% |
down 2.5% |
|
|
|
|
| Gross Margin |
24.9% |
up 1530 bps |
down 2750 bps |
| Loss from Operations |
$(84.7) million |
up 19.5% |
down 197.7% |
| Operating Margin |
(52.3)% |
up 880 bps |
down 10450 bps |
| Net Loss |
$(84.5) million |
up 17.7% |
down 203.5% |
| Net Margin |
(52.2)% |
up 750 bps |
down 10130 bps |
| EPS – Diluted |
$(1.59) |
up 13.1% |
down 205.3% |
|
|
|
|
|
|
|
|
|
|
|
|
| Quarterly Results - Non-GAAP |
|
Fiscal Q2 2025 |
Change vs.
Fiscal Q2 2024 |
Change vs.
Fiscal Q1 2025 |
| Loss from Operations |
$(27.4) million |
up 45.4% |
down 245% |
| Operating Margin |
(16.9)% |
up 1230 bps |
down 2830 bps |
| Net Loss |
$(27.9) million |
up 47.7% |
down 237.8% |
| Net Margin |
(17.2)% |
up 1370 bps |
down 2940 bps |
| EPS – Diluted |
$(0.52) |
up 45.3% |
down 240.5% |
A reconciliation between the GAAP and non-GAAP adjusted results is provided in the financial tables included at the end of this press release. See also the “Use of non-GAAP Financial Results” section of this press release.
Fusen Chen, Kulicke & Soffa’s President and Chief Executive Officer, stated, “We recently experienced more cautious order activity unique to certain Southeast Asia markets. Despite this near-term regional dynamic, we continue to support our global customer base, see positive core-market utilization data and remain well prepared to accelerate growth through Vertical Wire, Power-Semiconductor, Advanced Dispense and Thermo-Compression technology transitions."
Second Quarter Fiscal 2025 Financial Highlights
•Net revenue of $162.0 million.
•Gross margin of 24.9%.
•Net loss of $84.5 million or $(1.59) per share; non-GAAP net loss of $27.9 million or $(0.52) per fully diluted share.
•GAAP cash flow from operations of $79.9 million; Adjusted free cash flow of $78.0 million.
•Cash, cash equivalents, and short-term investments were $581.5 million as of March 29, 2025.
•The Company repurchased a total of 0.5 million shares of common stock at a cost of $21.3 million.
Third Quarter Fiscal 2025 Outlook
K&S currently expects net revenue in the third quarter of fiscal 2025 ending June 28, 2025 to be approximately $145 million +/- $10 million, GAAP diluted EPS to be approximately $(0.09) +/- 10%, and non-GAAP diluted EPS to be approximately $0.05 +/- 10%.
A reconciliation between the GAAP and non-GAAP financial outlook is provided in the financial tables included at the end of this press release.
Earnings Conference Webcast
A webcast to discuss these results will be held on May 7, 2025, beginning at 8:00 am ET. The live webcast link, supplemental earnings presentation, and archived webcast will be available at investor.kns.com. To access the audio-only portion of the live webcast, parties may call +1-877-407-8037, or internationally, +1-201-689-8037.
An audio-only replay of the webcast will also be available approximately one hour after the completion of the live call by calling +1-877-660-6853, or internationally, +1-201-612-7415 and referencing access code 13750874.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP ("GAAP") results, this press release also contains the following non-GAAP financial results: income from operations, operating margin, net income, net margin, net income per fully diluted share and adjusted free cash flow. The Company's non-GAAP results exclude amortization related to intangible assets acquired through business combinations, costs associated with restructuring and severance, equity-based compensation, acquisition and integration costs, impairment relating to assets acquired through business combinations, long-lived asset impairment relating to business cessation or disposal, impairment relating to equity investments, income tax expense/benefit arising from discrete tax items triggered by acquisition, disposal of business (both via a sale or an abandonment), restructuring and significant changes in tax laws, gain/loss on disposal of business, as well as tax benefits or expenses associated with the foregoing non-GAAP items. The non-GAAP adjustments may or may not be infrequent or nonrecurring in nature, but are a result of periodic or non-core operating activities. These non-GAAP measures are consistent with the way management analyzes and assesses the Company’s operating results. The Company believes these non-GAAP measures enhance investors’ understanding of the Company’s underlying operational performance, as well as their ability to compare the Company’s period-to-period financial results and the Company’s overall performance to that of its competitors.
Management uses both GAAP metrics as well as these non-GAAP metrics to evaluate the Company's operating and financial results. Non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in the Company’s industry, as other companies in the industry may calculate non-GAAP financial results differently. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on the Company’s reported financial results. The presentation of non-GAAP items is meant to supplement, but not substitute for, GAAP financial measures or information. The Company believes the presentation of non-GAAP results in combination with GAAP results provides better transparency to the investment community when analyzing business trends, providing meaningful comparisons with prior period performance and enhancing investors' ability to view the Company's results from management's perspective. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP measure discussed in this press release is contained in the financial tables at the end of this press release.
About Kulicke & Soffa
Kulicke & Soffa is a global leader in semiconductor assembly technology, advancing device performance across automotive, compute, industrial, memory and communications markets. Founded on innovation in 1951, K&S is uniquely positioned to overcome increasingly dynamic process challenges – creating and delivering long-term value by aligning technology with opportunity.
Caution Concerning Results, Forward-Looking Statements and Certain Risks Related to our Business
In addition to historical statements, this press release contains statements relating to future events and our future results. These statements are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. While these forward-looking statements represent our judgments and future expectations concerning our business, including the importance and competitiveness of our advanced display products and other emerging technology transitions, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, failures, delays or other problems arising from the negotiations with the applicable works council or trade unions; failures, delays or other problems arising from regulatory or judicial review of the activities concerning the Company's intended cessation of its Electronics Assembly equipment business, the persistent macroeconomic headwinds on our business, actual or potential inflationary pressures, interest rate and risk premium adjustments, falling customer sentiment, or economic recession caused directly or indirectly by geopolitical tensions, our ability to develop, manufacture and gain market acceptance of new products, our ability to operate our business in accordance with our business plan and the other factors listed or discussed in our Annual Report on Form 10-K for the fiscal year ended September 28, 2024, filed on November 14, 2024, and our other filings with the Securities and Exchange Commission. Kulicke and Soffa Industries, Inc. is under no obligation to (and expressly disclaims any obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
Contact:
|
|
|
|
|
|
| Kulicke and Soffa Industries, Inc. |
|
| Joseph Elgindy |
|
| Finance |
|
| P: +1-215-784-7518 |
|
|
|
|
|
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(In thousands, except per share and employee data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Three months ended |
|
Six months ended |
|
March 29, 2025 |
|
March 30, 2024 |
|
March 29, 2025 |
|
March 30, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net revenue |
$ |
161,986 |
|
|
$ |
172,074 |
|
|
$ |
328,110 |
|
|
$ |
343,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of sales |
121,602 |
|
|
155,603 |
|
|
200,642 |
|
|
246,896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross profit |
40,384 |
|
|
16,471 |
|
|
127,468 |
|
|
96,367 |
|
|
|
|
|
|
|
|
|
| Operating expenses (income): |
|
|
|
|
|
|
|
| Selling, general and administrative |
38,037 |
|
|
35,185 |
|
|
74,576 |
|
|
75,231 |
|
| Research and development |
37,220 |
|
|
37,704 |
|
|
75,028 |
|
|
74,514 |
|
| Impairment charges |
39,817 |
|
|
44,472 |
|
|
39,817 |
|
|
44,472 |
|
| Amortization of intangible assets |
1,171 |
|
|
1,325 |
|
|
2,417 |
|
|
2,672 |
|
|
|
|
|
|
|
|
|
| Gain relating to cessation of business |
— |
|
|
— |
|
|
(75,987) |
|
|
— |
|
| Restructuring |
8,806 |
|
|
2,940 |
|
|
9,635 |
|
|
2,940 |
|
| Total operating expenses |
125,051 |
|
|
121,626 |
|
|
125,486 |
|
|
199,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Loss)/income from operations |
(84,667) |
|
|
(105,155) |
|
|
1,982 |
|
|
(103,462) |
|
|
|
|
|
|
|
|
|
| Other income (expense): |
|
|
|
|
|
|
|
| Interest income |
5,622 |
|
|
8,848 |
|
|
11,974 |
|
|
18,747 |
|
| Interest expense |
(36) |
|
|
(18) |
|
|
(63) |
|
|
(40) |
|
|
|
|
|
|
|
|
|
| (Loss)/income before income taxes |
(79,081) |
|
|
(96,325) |
|
|
13,893 |
|
|
(84,755) |
|
| Income tax expense |
5,438 |
|
|
6,355 |
|
|
16,770 |
|
|
8,632 |
|
|
|
|
|
|
|
|
|
| Net loss |
$ |
(84,519) |
|
|
$ |
(102,680) |
|
|
$ |
(2,877) |
|
|
$ |
(93,387) |
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
| Basic |
$ |
(1.59) |
|
|
$ |
(1.83) |
|
|
$ |
(0.05) |
|
|
$ |
(1.66) |
|
| Diluted |
$ |
(1.59) |
|
|
$ |
(1.83) |
|
|
$ |
(0.05) |
|
|
$ |
(1.66) |
|
|
|
|
|
|
|
|
|
| Cash dividends declared per share |
$ |
0.205 |
|
|
$ |
0.20 |
|
|
$ |
0.41 |
|
|
$ |
0.40 |
|
|
|
|
|
|
|
|
|
| Weighted average shares outstanding: |
|
|
|
|
|
|
|
| Basic |
53,311 |
|
|
56,154 |
|
|
53,551 |
|
|
56,402 |
|
| Diluted |
53,311 |
|
|
56,154 |
|
|
53,551 |
|
|
56,402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Three months ended |
|
Six months ended |
| Supplemental financial data: |
March 29, 2025 |
|
March 30, 2024 |
|
March 29, 2025 |
|
March 30, 2024 |
| Depreciation and amortization |
$ |
5,011 |
|
|
$ |
6,967 |
|
|
$ |
10,024 |
|
|
$ |
14,952 |
|
| Capital expenditures |
2,716 |
|
|
3,846 |
|
|
4,827 |
|
|
7,379 |
|
| Equity-based compensation expense: |
|
|
|
|
|
|
|
| Cost of sales |
387 |
|
|
363 |
|
|
770 |
|
|
722 |
|
| Selling, general and administrative |
4,920 |
|
|
4,103 |
|
|
8,659 |
|
|
9,783 |
|
| Research and development |
2,186 |
|
|
1,766 |
|
|
4,205 |
|
|
3,584 |
|
| Total equity-based compensation expense |
$ |
7,493 |
|
|
$ |
6,232 |
|
|
$ |
13,634 |
|
|
$ |
14,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
As of |
|
March 29, 2025 |
|
March 30, 2024 |
|
|
|
|
| Number of employees |
2,677 |
|
|
2,925 |
|
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
|
March 29, 2025 |
|
September 28, 2024 |
|
|
| ASSETS |
|
|
| CURRENT ASSETS |
|
|
|
|
|
| Cash and cash equivalents |
$ |
286,519 |
|
|
$ |
227,147 |
|
|
|
|
|
|
|
|
|
| Short-term investments |
295,000 |
|
|
350,000 |
|
|
|
Accounts and other receivable, net of allowance for doubtful accounts of $65 and $49, respectively |
173,934 |
|
|
193,909 |
|
|
|
| Inventories, net |
155,655 |
|
|
177,736 |
|
|
|
| Prepaid expenses and other current assets |
37,092 |
|
|
46,161 |
|
|
|
|
|
|
|
|
|
| TOTAL CURRENT ASSETS |
948,200 |
|
|
994,953 |
|
|
|
|
|
|
|
|
|
| Property, plant and equipment, net |
60,118 |
|
|
64,823 |
|
|
|
| Operating right-of-use assets |
30,207 |
|
|
35,923 |
|
|
|
| Goodwill |
69,522 |
|
|
89,748 |
|
|
|
| Intangible assets, net |
6,215 |
|
|
25,239 |
|
|
|
| Deferred tax assets |
18,716 |
|
|
17,900 |
|
|
|
| Equity investments |
5,484 |
|
|
3,143 |
|
|
|
| Other assets |
6,802 |
|
|
8,433 |
|
|
|
| TOTAL ASSETS |
$ |
1,145,264 |
|
|
$ |
1,240,162 |
|
|
|
|
|
|
|
|
|
| LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
| Accounts payable |
48,396 |
|
|
58,847 |
|
|
|
| Operating lease liabilities |
6,702 |
|
|
7,718 |
|
|
|
| Accrued expenses and other current liabilities |
96,125 |
|
|
90,802 |
|
|
|
| Income taxes payable |
31,807 |
|
|
26,427 |
|
|
|
| TOTAL CURRENT LIABILITIES |
183,030 |
|
|
183,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred tax liabilities |
35,215 |
|
|
34,594 |
|
|
|
| Income taxes payable |
20,156 |
|
|
31,352 |
|
|
|
| Operating lease liabilities |
29,575 |
|
|
33,245 |
|
|
|
| Other liabilities |
13,122 |
|
|
13,168 |
|
|
|
| TOTAL LIABILITIES |
281,098 |
|
|
296,153 |
|
|
|
|
|
|
|
|
|
| SHAREHOLDERS' EQUITY |
|
|
|
|
|
| Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 53,032 and 53,854 shares, respectively |
605,322 |
|
|
596,703 |
|
|
|
| Treasury stock, at cost, 32,332 and 31,510 shares, respectively |
(935,633) |
|
|
(881,830) |
|
|
|
| Retained earnings |
1,217,808 |
|
|
1,242,558 |
|
|
|
| Accumulated other comprehensive loss |
(23,331) |
|
|
(13,422) |
|
|
|
| TOTAL SHAREHOLDERS' EQUITY |
$ |
864,166 |
|
|
$ |
944,009 |
|
|
|
|
|
|
|
|
|
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
$ |
1,145,264 |
|
|
$ |
1,240,162 |
|
|
|
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Three months ended |
|
Six months ended |
| |
March 29, 2025 |
|
March 30, 2024 |
|
March 29, 2025 |
|
March 30, 2024 |
| Net cash provided by / (used in) operating activities |
$ |
79,877 |
|
|
$ |
(20,148) |
|
|
$ |
98,779 |
|
|
$ |
(27,479) |
|
| Net cash provided by / (used in) investing activities |
(38,415) |
|
|
3,429 |
|
|
43,624 |
|
|
(57,112) |
|
| Net cash used in financing activities |
(33,506) |
|
|
(47,672) |
|
|
(81,958) |
|
|
(85,796) |
|
| Effect of exchange rate changes on cash and cash equivalents |
238 |
|
|
(521) |
|
|
(1,073) |
|
|
733 |
|
| Changes in cash and cash equivalents |
8,194 |
|
|
(64,912) |
|
|
59,372 |
|
|
(169,654) |
|
| Cash and cash equivalents, beginning of period |
278,325 |
|
|
424,660 |
|
|
227,147 |
|
|
529,402 |
|
| Cash and cash equivalents, end of period |
$ |
286,519 |
|
|
$ |
359,748 |
|
|
$ |
286,519 |
|
|
$ |
359,748 |
|
|
|
|
|
|
|
|
|
| Short-term investments |
295,000 |
|
|
275,000 |
|
|
295,000 |
|
|
275,000 |
|
| Total cash, cash equivalents and short-term investments |
$ |
581,519 |
|
|
$ |
634,748 |
|
|
$ |
581,519 |
|
|
$ |
634,748 |
|
|
|
|
|
|
|
|
|
Reconciliation of U.S. GAAP
to Non-GAAP Income from Operations and Operating Margin
(In thousands, except percentages)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three months ended |
|
|
March 29, 2025 |
|
March 30, 2024 |
|
December 28, 2024 |
| Net revenue |
|
$ |
161,986 |
|
|
$ |
172,074 |
|
|
166,124 |
|
| U.S. GAAP (loss)/income from operations |
|
(84,667) |
|
|
(105,155) |
|
|
86,649 |
|
| U.S. GAAP operating margin |
|
(52.3) |
% |
|
(61.1) |
% |
|
52.2 |
% |
|
|
|
|
|
|
|
| Pre-tax non-GAAP items: |
|
|
|
|
|
|
| Amortization related to intangible assets |
|
1,171 |
|
|
1,325 |
|
|
1,246 |
|
| Restructuring |
|
8,806 |
|
|
2,940 |
|
|
829 |
|
| Equity-based compensation |
|
7,493 |
|
|
6,232 |
|
|
6,141 |
|
| Impairment charges |
|
39,817 |
|
|
44,472 |
|
|
— |
|
|
|
|
|
|
|
|
| Gain relating to cessation of business |
|
— |
|
|
— |
|
|
(75,987) |
|
| Non-GAAP (loss)/income from operations |
|
$ |
(27,380) |
|
|
$ |
(50,186) |
|
|
$ |
18,878 |
|
| Non-GAAP operating margin |
|
(16.9) |
% |
|
(29.2) |
% |
|
11.4 |
% |
|
|
|
|
|
|
|
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and Non-GAAP Net Margin and
U.S. GAAP net income per share to Non-GAAP net income per share
(In thousands, except percentages and per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three months ended |
|
|
March 29, 2025 |
|
March 30, 2024 |
|
December 28, 2024 |
| Net revenue |
|
$ |
161,986 |
|
|
$ |
172,074 |
|
|
$ |
166,124 |
|
| U.S. GAAP net (loss)/income |
|
(84,519) |
|
|
(102,680) |
|
|
81,642 |
|
| U.S. GAAP net margin |
|
(52.2) |
% |
|
(59.7) |
% |
|
49.1 |
% |
|
|
|
|
|
|
|
| Non-GAAP adjustments: |
|
|
|
|
|
|
| Amortization related to intangible assets |
|
1,171 |
|
|
1,325 |
|
|
1,246 |
|
| Restructuring |
|
8,806 |
|
|
2,940 |
|
|
829 |
|
| Equity-based compensation |
|
7,493 |
|
|
6,232 |
|
|
6,141 |
|
| Impairment charges |
|
39,817 |
|
|
44,472 |
|
|
— |
|
|
|
|
|
|
|
|
| Gain relating to cessation of business |
|
— |
|
|
— |
|
|
(75,987) |
|
|
|
|
|
|
|
|
Net income tax (benefit)/expense on non-GAAP items |
|
(639) |
|
|
(5,534) |
|
|
6,349 |
|
| Total non-GAAP adjustments |
|
$ |
56,648 |
|
|
$ |
49,435 |
|
|
$ |
(61,422) |
|
| Non-GAAP net (loss)/income |
|
$ |
(27,871) |
|
|
$ |
(53,245) |
|
|
$ |
20,220 |
|
| Non-GAAP net margin |
|
(17.2) |
% |
|
(30.9) |
% |
|
12.2 |
% |
|
|
|
|
|
|
|
U.S. GAAP net (loss)/income per share: |
|
|
|
|
|
|
| Basic |
|
(1.59) |
|
|
(1.83) |
|
|
1.52 |
|
Diluted(a) |
|
(1.59) |
|
|
(1.83) |
|
|
1.51 |
|
|
|
|
|
|
|
|
Non-GAAP adjustments per share:(b) |
|
|
|
|
|
|
| Basic |
|
1.07 |
|
|
0.88 |
|
|
(1.14) |
|
| Diluted |
|
1.07 |
|
|
0.88 |
|
|
(1.14) |
|
|
|
|
|
|
|
|
Non-GAAP net (loss)/income per share: |
|
|
|
|
|
|
| Basic |
|
(0.52) |
|
|
(0.95) |
|
|
0.38 |
|
Diluted(c) |
|
(0.52) |
|
|
(0.95) |
|
|
0.37 |
|
|
|
|
|
|
|
|
| Weighted average shares outstanding: |
|
|
|
|
|
|
| Basic |
|
53,311 |
|
|
56,154 |
|
|
53,791 |
|
| Diluted |
|
53,311 |
|
|
56,154 |
|
|
54,212 |
|
|
|
|
|
|
|
|
(a)GAAP diluted net earnings per share reflects any dilutive effect of outstanding restricted stock, but that effect is excluded when calculating GAAP diluted net loss per share because it would be anti-dilutive.
(b)Non-GAAP adjustments per share include amortization related to intangible assets acquired through business combinations, costs associated with restructuring and severance, equity-based compensation expenses, impairment relating to assets acquired through business combinations, long-lived asset impairment relating to business cessation or disposal, gain relating to disposal or cessation of business, and income tax effects associated with the foregoing non-GAAP items.
(c)Non-GAAP diluted net earnings per share reflects any dilutive effect of outstanding restricted stock, but that effect is excluded when calculating Non-GAAP diluted net loss per share because it would be anti-dilutive.
Reconciliation of U.S. GAAP Cash provided by Operating Activities
to Non-GAAP Adjusted Free Cash Flow
(In thousands, except percentages)
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three months ended |
|
|
March 29, 2025 |
|
March 30, 2024 |
|
December 28, 2024 |
U.S. GAAP net cash provided by / (used in) operating activities |
|
$ |
79,877 |
|
|
$ |
(20,148) |
|
|
$ |
18,902 |
|
Purchases of property, plant and equipment |
|
(1,954) |
|
|
(6,571) |
|
|
(10,202) |
|
| Proceeds from sales of property, plant and equipment |
|
60 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
| Non-GAAP adjusted free cash flow |
|
77,983 |
|
|
(26,719) |
|
|
8,700 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of U.S. GAAP to Non-GAAP Outlook
(In millions, except per share data)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third quarter of fiscal 2025 ending June 28, 2025 |
|
|
GAAP Outlook |
|
Adjustments |
|
Non-GAAP Outlook |
| Net revenue |
|
$145 million
+/- $10 million
|
|
— |
|
$145 million
+/- $10 million
|
| Operating expenses |
|
$76.0 million
+/- 2%
|
|
$8.0 million B,C,D |
|
$68.0 million
+/- 2%
|
Diluted EPS(1) |
|
$(0.09)
+/- 10%
|
|
$0.14 A, B, C, D, E |
|
$0.05
+/- 10%
|
|
|
|
|
|
|
|
| Non-GAAP Adjustments |
|
|
|
|
|
|
A. Equity-based compensation - Cost of sales |
|
|
|
0.4 |
| B. Equity-based compensation - Selling, general and administrative and Research and development |
|
|
|
7.2 |
C. Amortization related to intangible assets |
|
|
|
0.3 |
| D. Restructuring expenses |
|
|
|
|
|
0.5 |
| E. Net income tax effect of the above items |
|
|
|
(0.6) |
|
|
|
|
|
|
|
(1) GAAP and non-GAAP diluted EPS based on approximately 52.6 million diluted weighted average shares outstanding.
The tables above reconcile our GAAP to non-GAAP guidance based on the current outlook. The guidance does not incorporate the impact of any potential business combinations, divestitures, restructuring activities, strategic investments and other significant transactions. The timing and impact of such items are dependent on future events that may be uncertain or outside of our control.
エドガーで原本を確認する
